Each year, September is dedicated to National Sickle Cell Awareness Month. First officially recognized by the federal government in 1983, National Sickle Cell Awareness Month calls attention to sickle cell disease, a genetic disease that researchers estimate affects between 90,000 and 100,000 Americans, and millions more around the world.
Join NHLBI’s Facebook LIVE event, Sickle Cell Research Directions: Advancing Toward a Widely Available Cure, as we explore a variety of sickle cell disease advances and how they are paving the way for successful treatments, and eventually a cure. If you’d like to submit a question in advance, feel free to post your comment or question here.
To tune in live, visit https://www.facebook.com/NHLBI/videos/10155749389983833/ on Thursday, September 14 at 11:45 a.m. (EST).
Sickle Cell Research Directions: Advancing Toward a Widely Available Cure features:
- Courtney Fitzhugh, M.D. Clinical Tenure Track Investigator, Laboratory of Early Sickle Mortality Prevention, National Heart, Lung, and Blood Institute
- W. Keith Hoots, M.D., Director of the Division of Blood Diseases and Resources, National Heart, Lung, and Blood Institute
- John F. Tisdale, M.D., Senior Investigator, Molecular and Clinical Hematology Section, National Heart, Lung, and Blood Institute
- Kirti Dasu, NHLBI Clinical Trial Participant and Sickle Cell Disease Patient